Permanent product Record

PROSUPPS

Dr. JEKYLL Signature V2

CURRENTRecord last observed August 3, 2026

ProSupps Dr. JEKYLL Signature V2 has a current Record. Last observed August 3, 2026. The current public formula contains 9 declared ingredient lines. Comparable formula history is not yet available.

Current Record

The current declared formula.

Printed label wording stays separate from FormulaSignal's normalized identity. Current formula observed August 3, 2026.

Serving size
Not recorded
Servings
Not recorded
Caffeine
Not computable from current evidence
Formula scope
FLAVOR SPECIFIC
ProSupps Dr. JEKYLL Signature V2, current declared formula observed August 3, 2026. Each row gives the printed label wording, the declared amount, and FormulaSignal's normalized identity.
Original label wordingDeclared amountNormalized identity
Beta Alanine3200 mgbeta-alanine
Creatine Monohydrate2500 mgcreatine monohydrate
nooLVL (Inositol-Enhanced Bonded Arginine Silicate)800 mgnoolvl inositol-enhanced bonded arginine silicate
Choline Bitartrate500 mgcholine bitartrate
L-Tyrosine500 mgl-tyrosine
Panax ginseng Extract (20% ginsenosides) (stem and leaf)50 mgpanax ginseng extract 20% ginsenosides stem and leaf
Ashwagandha Root Extract (Withania somnifera) (std. to 5% withanolides)125 mgashwagandha root extract withania somnifera std. to 5% withanolides
CaloriBurn GP (Aframomum melegueta Extract) (seed) (12.5% 6-Paradol)30 mgcaloriburn gp aframomum melegueta extract seed 12.5% 6-paradol
Black Pepper Extract5 mgblack pepper extract

Serving economics

Facts and calculations stay labeled.

Reliable serving economics are not available for this Record.

Historical timeline

Comparable formula states.

Dates below are observation dates. They are not exact reformulation dates.

Historical formula evidence is not yet sufficient for a reliable comparison. This does not establish that the product never changed.

Confirmed Signals

Reviewed changes in the public Record.

No confirmed public Signal is associated with this product. This is not a claim that the product never changed.

Research-dose context

Selected evidence, not a universal effective dose.

These comparisons retain the studied protocol, source, and limitations. They do not establish safety, effectiveness, or a dose recommendation for this product.

A2

Beta-alanine

Product declaration
Beta Alanine: 3200 mg
Selected studied range
4000 to 6000 mg
Protocol and duration
per day in divided doses, for at least 2 to 4 weeks, not as a single pre-workout dose
Studied context
Studied for high-intensity exercise capacity in the 60-240 second range via elevation of muscle carnosine, which acts as an intracellular pH buffer against acidosis. ISSN 2015 position stand: greatest performance benefits in "open end-point" tasks/time trials lasting 1-4 minutes; some benefit noted in aerobic exercise up to roughly 25 minutes; attenuation of neuromuscular fatigue, particularly noted in older adults.
Limitations
Strength/resistance-training outcomes remain mixed; training volume may increase without a clear strength gain. Tasks under 60 seconds do not show benefit. Endurance benefit beyond about 25 minutes is not established. Long-term safety data beyond roughly a year, and effects in special/tactical populations, are flagged as needing more research.

Selected evidence: ISSN position stand on beta-alanine, 2015 · Open source

A2

Creatine monohydrate

Product declaration
Creatine Monohydrate: 2500 mg
Selected studied range
3000 to 5000 mg
Protocol and duration
per day maintenance, after an optional loading phase
Studied context
The ISSN 2017 position stand calls creatine monohydrate "the most effective ergogenic nutritional supplement currently available to athletes" for increasing high-intensity/intermittent exercise capacity and lean body mass during training. It also describes research into post-exercise recovery, injury prevention, thermoregulation, rehabilitation, concussion/spinal-cord neuroprotection, and use in clinical populations (aging-related sarcopenia, neurodegenerative disease, type 2 diabetes glycemic control), while noting creatine is "of little value" for pure endurance sports (per NIH ODS).
Limitations
ISSN 2017 states it is not yet established whether other creatine forms (e.g., creatine nitrate, or precursors like guanidinoacetic acid/GAA) produce greater muscle or brain creatine uptake than monohydrate. This is described as an active area of research, not a settled finding.

Selected evidence: ISSN position stand on creatine safety and efficacy, 2017 · Open source

A1

Choline bitartrate

Product declaration
Choline Bitartrate: 500 mg
Selected studied range
425 to 550 mg
Protocol and duration
Adequate Intake for adults, a nutrient reference and not an ergogenic dose
Studied context
NIH ODS's Choline Health Professional fact sheet establishes choline's core physiological roles: synthesis of phosphatidylcholine and sphingomyelin for cell-membrane structure, acetylcholine (a neurotransmitter for memory, mood, and muscle control) production, methyl-group donation, gene-expression modulation, and brain development. Choline bitartrate is named as one of three supplement forms (with phosphatidylcholine and lecithin).
Limitations
NIH ODS states explicitly: "No studies have compared the relative bioavailability of choline from these different forms". Meaning choline bitartrate's absorption/efficacy relative to phosphatidylcholine, lecithin, or non-bitartrate forms (like alpha-GPC) is not established by NIH's own review.

Selected evidence: NIH ODS, Choline fact sheet · Open source

A2

L-tyrosine

Product declaration
L-Tyrosine: 500 mg
Selected studied range
2000 to 2000 mg
Protocol and duration
per day for five days, in the cadet study
Studied context
Studied as the dietary precursor to norepinephrine for mitigating cognitive performance decrements under acute stress. A 2015 Military Medicine evidence review (rapid evidence assessment, 14 trials: 10 RCTs + 4 controlled clinical trials) issued a "weak recommendation" in favor of tyrosine for cognitive stress specifically, stating "all studies showed a positive effect" on that outcome. A widely cited primary study (Deijen et al. 1999, Brain Research Bulletin) gave cadets 2 g tyrosine daily for five days during a combat training course and found better memory and tracking-task performance, plus lower systolic blood pressure, versus a carbohydrate control.
Limitations
The 2015 Military Medicine review states explicitly that "no recommendation could be made" for tyrosine's effect on physical performance under stressful physical conditions, and concludes "available evidence is insufficient to make confident recommendations on the effectiveness of tyrosine for mitigating stress effects on physical/cognitive performance" overall, despite the positive signal on cognition. A separate heat-stress study found tyrosine ingestion did not influence cognitive function or physical performance during exercise heat stress despite raised serum tyrosine. NIH ODS's exercise/athletic-performance fact sheet does not cover tyrosine at all.

Selected evidence: Deijen et al., Brain Research Bulletin, 1999

Cautions and regulatory records

A filing and a documented risk are not the same thing.

These attach to declared ingredients, not to this product as a whole. Nothing here establishes that the product is safe or unsafe. Talk with a qualified health professional.

No documented caution is recorded against the declared ingredients on this Record. That is not a finding that the product is safe.

Where the sources disagree

What we could not read cleanly.

A disagreement between sources is recorded rather than smoothed into one confident number. None of these is a Signal.

No source conflict is recorded on this Record. That is not a claim that every source agrees, only that none we read disagreed.

Evidence

Audit the material claims.

  • ProSupps

    P1 current formula source · observed August 3, 2026 · accessed August 3, 2026

    Open source evidence

Go deeper

Ask now, or keep watch.

No released consumer report is available for this product. Browse Reports.